SCHEMBL7740686

SCHEMBL7740686

CC1=CC(C)(C)Oc2ccc(C)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPK1 P28482 1/20 0.43
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
ATM Q13315 4/20 0.41
HTT P42858 1/20 0.41
RAD52 P43351 1/20 0.39
RARA P10276 2/20 0.38
RARB P10826 2/20 0.38
RARG P13631 2/20 0.38
PGR P06401 1/20 0.37
NPSR1 Q6W5P4 3/20 0.36
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21408598 0.81 MAPT (0.49) KDM4EALDH1A1MAPTMEN1CYP3A4
SCHEMBL14862508 0.81 PGR (0.39) MAPTHTTRARARARBRARG
SCHEMBL24727712 0.79 RARA (0.57) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL7028269 0.79 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL10653165 0.78 RARA (0.39) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL10656659 0.78 KDM4E (0.37) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL6535545 0.76 ALDH1A1 (0.41) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL17746857 0.75 KDM4E (0.35) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL21408597 0.75 ALDH1A1 (0.54) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL16291922 0.75 LPL (0.39) CA1CA2CA4CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165276-A1 NOVEL USE OF SUBSTITUTED 2H-CHROMENS AND THEIR DERIVATIVES DSM IP ASSETS B.V. (NL) 2023-06-01 US disclosed
US-6410678-B1 HYDROXYL END GROUPS TEIJIN LIMITED (JP) 2002-06-25 US disclosed
EP-1149852-A1 AROMATIC POLYCARBONATE, PROCESS FOR PRODUCING THE SAME, AND MOLDED ARTICLE TEIJIN LIMITED (JP) 2001-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165276-A1 NOVEL USE OF SUBSTITUTED 2H-CHROMENS AND THEIR DERIVATIVES CRY1, HRH3, CYP4F12 KDM4E 393/4885ALDH1A1 2102/4885MAPT 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.